Asia Pacific In Vitro Diagnostics (IVD) Market size to exceed $23.7bn by 2027, says Graphical Research
27 avr. 2022 19h00 HE
|
Graphical Research
Pune, India, April 27, 2022 (GLOBE NEWSWIRE) -- As per a recent industry report put forward by Graphical Research, the Asia Pacific In Vitro Diagnostics (IVD) market is forecast to register its...
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference
26 avr. 2022 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its participation and the presentation of HemeScreen,...
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent Application for Use of PV-10® Immunotherapy in Hematology
26 avr. 2022 07h30 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 26, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent application 16/688,319,...
Provectus Biopharmaceuticals Seeks Stockholder Approval at 2022 Annual Meeting for Authority to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
19 avr. 2022 16h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 19, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that, in conjunction with the filing of the Company’s preliminary 2022 proxy statement (Pre-14A), Provectus’...
IVD Contract Research Organization Market ($8Bn by 2028) Growth Forecast at 7.8% CAGR During 2021 to 2028 COVID Impact and Global Analysis by The Insight Partners
30 mars 2022 13h52 HE
|
The Insight Partners
New York, March 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “IVD Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis...
Provectus Biopharmaceuticals Announces Synthesis of New Halogenated Xanthene Small Molecule
24 mars 2022 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 24, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has successfully developed and manufactured a second halogenated xanthene (HX), adding to...
Veterinary Diagnostics Market Worth $9.58 billion by 2029 - Exclusive Report by Meticulous Research®
09 févr. 2022 08h48 HE
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Feb. 09, 2022 (GLOBE NEWSWIRE) -- According to a new market research report “Veterinary Diagnostics Market by Product (Consumables {Leukemia, Influenza}, System, Software),...
Rapid Diagnostics Market Worth $18.20 Billion by 2029 — Exclusive Report by Meticulous Research®
01 févr. 2022 07h00 HE
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Feb. 01, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled "Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral...
Starton Therapeutics Receives Clinical Trial Authorization in Europe to Initiate Phase 1 Clinical Trial of STAR-LLD Continuous Delivery Lenalidomide
10 janv. 2022 08h30 HE
|
Starton Therapeutics, Inc.
STAR-LLD is the first continuous delivery immunomodulatory drug (IMiD) in development to expand the use of lenalidomide in multiple myeloma and become the first IMiD for CLLOn track to complete...
HM43239 Demonstrates Durable Clinical Benefit in Acute Myeloid Leukemia
13 déc. 2021 16h30 HE
|
Aptose Biosciences, Inc.
HM43239 Data Featured in Oral Presentation at the American Society of Hematology Annual Meeting Aptose Presents Highlights from Luxeptinib and APTO-253 and Provides Corporate Update SAN DIEGO,...